Logo image
Sign in
Severe bradycardia: An unreported adverse infusion-associated reaction (IAR) with alemtuzumab
Journal article   Peer reviewed

Severe bradycardia: An unreported adverse infusion-associated reaction (IAR) with alemtuzumab

E. Nerrant, Eric Thouvenot and G. Castelnovo
Revue Neurologique, Vol.173(3), pp.175 - 176
03/2017
PMID: 28320519
url
Find in HALView

Metrics

1 Record Views

Details

Logo image